Logo image of BOW

BOWHEAD SPECIALTY HOLDINGS I (BOW) Stock Fundamental Analysis

NYSE:BOW - New York Stock Exchange, Inc. - US10240L1026 - Common Stock - Currency: USD

33.16  -0.47 (-1.4%)

Fundamental Rating

4

Overall BOW gets a fundamental rating of 4 out of 10. We evaluated BOW against 144 industry peers in the Insurance industry. The financial health of BOW is average, but there are quite some concerns on its profitability. BOW is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year BOW was profitable.
BOW Yearly Net Income VS EBIT VS OCF VS FCFBOW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 50M 100M 150M 200M

1.2 Ratios

BOW has a better Return On Assets (3.21%) than 64.08% of its industry peers.
BOW's Return On Equity of 13.62% is fine compared to the rest of the industry. BOW outperforms 60.56% of its industry peers.
BOW has a better Return On Invested Capital (5.71%) than 80.99% of its industry peers.
Industry RankSector Rank
ROA 3.21%
ROE 13.62%
ROIC 5.71%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BOW Yearly ROA, ROE, ROICBOW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2 4 6 8 10

1.3 Margins

BOW has a Profit Margin of 8.42%. This is comparable to the rest of the industry: BOW outperforms 54.23% of its industry peers.
BOW has a Operating Margin of 19.17%. This is in the better half of the industry: BOW outperforms 76.06% of its industry peers.
Industry RankSector Rank
OM 19.17%
PM (TTM) 8.42%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BOW Yearly Profit, Operating, Gross MarginsBOW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 5 10 15

More info and screens

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BOW is destroying value.
BOW has about the same amout of shares outstanding than it did 1 year ago.
There is no outstanding debt for BOW. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BOW Yearly Shares OutstandingBOW Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 10M 20M 30M
BOW Yearly Total Debt VS Total AssetsBOW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 200M 400M 600M 800M 1B

2.2 Solvency

There is no outstanding debt for BOW. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z N/A
ROIC/WACC0.63
WACC9.04%
BOW Yearly LT Debt VS Equity VS FCFBOW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 50M 100M 150M 200M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
BOW Yearly Current Assets VS Current LiabilitesBOW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 5M 10M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 122.52% over the past year.
BOW shows a strong growth in Revenue. In the last year, the Revenue has grown by 51.06%.
EPS 1Y (TTM)122.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)51.06%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 34.96% on average over the next years. This is a very strong growth
BOW is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 26.95% yearly.
EPS Next Y68.02%
EPS Next 2Y43.5%
EPS Next 3Y34.96%
EPS Next 5YN/A
Revenue Next Year38.97%
Revenue Next 2Y32.69%
Revenue Next 3Y26.95%
Revenue Next 5YN/A

3.3 Evolution

BOW Yearly Revenue VS EstimatesBOW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 100M 200M 300M 400M 500M
BOW Yearly EPS VS EstimatesBOW Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 0.5 1 1.5

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

BOW is valuated rather expensively with a Price/Earnings ratio of 20.99.
Based on the Price/Earnings ratio, BOW is valued a bit more expensive than 71.83% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 29.43, BOW is valued a bit cheaper.
A Price/Forward Earnings ratio of 20.27 indicates a rather expensive valuation of BOW.
Based on the Price/Forward Earnings ratio, BOW is valued a bit more expensive than the industry average as 66.90% of the companies are valued more cheaply.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.65, BOW is valued at the same level.
Industry RankSector Rank
PE 20.99
Fwd PE 20.27
BOW Price Earnings VS Forward Price EarningsBOW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BOW indicates a somewhat cheap valuation: BOW is cheaper than 65.49% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.37
BOW Per share dataBOW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

BOW's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BOW's earnings are expected to grow with 34.96% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.31
PEG (5Y)N/A
EPS Next 2Y43.5%
EPS Next 3Y34.96%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BOW!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BOWHEAD SPECIALTY HOLDINGS I

NYSE:BOW (2/26/2025, 12:49:55 PM)

33.16

-0.47 (-1.4%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)02-25 2025-02-25/bmo
Earnings (Next)N/A N/A
Inst Owners90.25%
Inst Owner Change-92.46%
Ins Owners4.07%
Ins Owner Change-499.01%
Market Cap1.08B
Analysts72
Price Target37.13 (11.97%)
Short Float %1.45%
Short Ratio3.57
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.16%
Min EPS beat(2)2.89%
Max EPS beat(2)9.43%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.01%
Min Revenue beat(2)-4.62%
Max Revenue beat(2)-1.41%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)8.98%
PT rev (3m)10.98%
EPS NQ rev (1m)-10.05%
EPS NQ rev (3m)-10.05%
EPS NY rev (1m)-1.12%
EPS NY rev (3m)-2.74%
Revenue NQ rev (1m)-7.13%
Revenue NQ rev (3m)-7.13%
Revenue NY rev (1m)-0.33%
Revenue NY rev (3m)-0.34%
Valuation
Industry RankSector Rank
PE 20.99
Fwd PE 20.27
P/S 1.84
P/FCF N/A
P/OCF N/A
P/B 2.97
P/tB 2.97
EV/EBITDA 8.37
EPS(TTM)1.58
EY4.76%
EPS(NY)1.64
Fwd EY4.93%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS18.06
BVpS11.17
TBVpS11.17
PEG (NY)0.31
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.21%
ROE 13.62%
ROCE 7.38%
ROIC 5.71%
ROICexc 6.25%
ROICexgc 8.64%
OM 19.17%
PM (TTM) 8.42%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-ScoreN/A
WACC9.04%
ROIC/WACC0.63
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)122.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y68.02%
EPS Next 2Y43.5%
EPS Next 3Y34.96%
EPS Next 5YN/A
Revenue 1Y (TTM)51.06%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year38.97%
Revenue Next 2Y32.69%
Revenue Next 3Y26.95%
Revenue Next 5YN/A
EBIT growth 1Y79.74%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y30.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y30.05%
OCF growth 3YN/A
OCF growth 5YN/A